Actively Recruiting
Neuroimaging Reveals Treatment-related Changes in Developmental Language Disorder: A Randomized Controlled Trial Supplement
Led by University of Toronto · Updated on 2026-06-02
45
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Toronto
Lead Sponsor
H
Holland Bloorview Kids Rehabilitation Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Late talking affects about 10% to 20% of children under 3 years old and is marked by delays in vocabulary and grammar similar to those seen in preschoolers with developmental language disorder (DLD). Researchers are studying the brain and behavioral factors that influence late talking, aiming to better understand the memory and language processes involved and how they relate to changes from treatment. This study builds on existing research about memory systems and brain structures involved in language learning. The study compares children with late talking who receive a structured intervention program to improve grammar, vocabulary, and communication, with those who do not receive treatment during the study. The intervention includes teaching parents and providing direct support to children over 6 to 8 weeks. Additionally, typically developing peers are included to help understand differences related to late talking. Brain imaging using diffusion techniques will measure changes in brain connectivity before, after, and following a break in treatment. Participants will undergo brain scans and behavioral assessments at multiple points: before the intervention, after 6 to 8 weeks of treatment, and after a follow-up period. Researchers will measure language skills using various tools, including parent and clinician reports and play-based samples. The study also collects qualitative data from parents and clinicians to understand treatment outcomes. The total participation time covers these assessments and imaging sessions, helping to link brain changes with language improvements and treatment effects.
CONDITIONS
Brief Title
Using Neuroimaging and Behavioral Assessments to Understand Late Talking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child and parent are primarily monolingual/native English speakers
- Child is enrolled at one of the participating facilities
- Child is recruited via word of mouth, including social media
- Child is between 18 and 30 months of age
- Child has no contraindications to magnetic resonance imaging (e.g., no intracranial metal implants, no claustrophobia)
- Child has no uncorrected vision problems
You will not qualify if you...
- Child does not meet criteria for late talking or typical development
- Child meets standard magnetic resonance imaging exclusion criteria
- Child was born before 37 weeks or after 42 weeks of gestation
- Child is placed in special education based on ability or behavior
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 to 8 weeks
Participants who are late talkers receive an intervention program designed to support speech and language development, including parent coaching and direct child support, over 6 to 8 weeks.
1 to 2 visits per week
Duration - 8 to 9 weeks
Participants are assessed after the treatment period to measure changes in language and brain connectivity.
1 to 2 visits during follow-up period
Trial Site Locations
Total: 2 locations
1
Grandview Kids
Oshawa, Ontario, Canada, L1H0C8
Actively Recruiting
2
Speech Specialists
Toronto, Ontario, Canada, M1X0C3
Actively Recruiting
Research Team
K
Karla N Washington, PhD
N
Nicole Bazzocchi, MhSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here